Undre NA and Schäfer A |
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. |
1998 |
Transplant. Proc. |
pmid:9636512
|
Thomson AW |
Interspecies comparison of the immunosuppressive efficacy and safety of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689883
|
Smoter P et al. |
Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. |
2014 |
Transplant. Proc. |
pmid:25380918
|
Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Youhua Z et al. |
Clinical study of FK 506 in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:11119900
|
Klintmalm GB et al. |
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679828
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721261
|
Washburn WK et al. |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8623214
|
Sugioka A et al. |
FK 506 inhibits tolerance induction in mice liver transplantation. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808576
|
Brook NR et al. |
Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamune. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808577
|
Shitrit D et al. |
Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient. |
2003 |
Transplant. Proc. |
pmid:12644073
|
Crespo-Leiro MG et al. |
Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy. |
2002 |
Transplant. Proc. |
pmid:11959213
|
Ringe B et al. |
Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept. |
1998 |
Transplant. Proc. |
pmid:9636573
|
Tashiro H et al. |
Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats. |
2000 |
Transplant. Proc. |
pmid:11120201
|
Torio A et al. |
Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients. |
2012 |
Transplant. Proc. |
pmid:23146466
|
Akselband Y et al. |
Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. |
1991 |
Transplant. Proc. |
pmid:1721292
|
Jurewicz WA |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report. |
1999 |
Transplant. Proc. |
pmid:10576048
|
Kim SJ et al. |
Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15518759
|
Schreiber SL et al. |
Immunophilin-ligand complexes as probes of intracellular signaling pathways. |
1991 |
Transplant. Proc. |
pmid:1721293
|
Klintmalm GB |
Clinical use of FK 506 in liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623484
|
Boran M et al. |
Determining renal resistive and pulsatility indexes long-term after kidney transplantation in kidney transplant recipients on cyclosporine a-, tacrolimus-, or sirolimus-based regimens. |
2014 |
Transplant. Proc. |
pmid:24935296
|
Butt TR et al. |
Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506. |
1996 |
Transplant. Proc. |
pmid:8623486
|
Burg M et al. |
Enteric-coated mycophenolate sodium reduces gastrointestinal symptoms in renal transplant patients. |
2009 |
Transplant. Proc. |
pmid:20005359
|
Schneeberger H et al. |
Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center. |
1998 |
Transplant. Proc. |
pmid:9636642
|
Yamazaki R et al. |
Interindividual variation of maximal blood levels of tacrolimus after its oral administration in hematopoietic cell transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19545738
|
Dammeijer PF et al. |
Combined effect of low-dose FK 506 and cyclosporine A on skin graft survival. |
1990 |
Transplant. Proc. |
pmid:1697116
|
Imai K et al. |
Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression. |
1990 |
Transplant. Proc. |
pmid:1697117
|
Laftavi MR et al. |
African American renal transplant recipients (RTR) require higher tacrolimus doses to achieve target levels compared to white RTR: does clotrimazole help? |
2013 |
Transplant. Proc. |
pmid:24314941
|
Gavlik A et al. |
Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up. |
1997 |
Transplant. Proc. |
pmid:9365633
|
Spada M et al. |
Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518142
|
Foroncewicz B et al. |
Anti-CD25 and tacrolimus therapy may not prevent early primary biliary cirrhosis recurrence after liver transplantation: two case reports. |
2003 |
Transplant. Proc. |
pmid:14529924
|
Reggiani P et al. |
A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919435
|
Ushigome H et al. |
Pediatric living-related renal transplantation under tacrolimus as the primary immunosuppressive agent. |
2003 |
Transplant. Proc. |
pmid:12591350
|
Kai N et al. |
A study on the timing of immunologic priming in autoimmune insulitis in NOD mice. |
1992 |
Transplant. Proc. |
pmid:1376511
|
Langrehr JM et al. |
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. |
1995 |
Transplant. Proc. |
pmid:7533373
|
Kim SW et al. |
Decreased formation of nitric oxide in rats treated with FK506. |
2003 |
Transplant. Proc. |
pmid:12591357
|
Huang CT et al. |
Higher Variability of Tacrolimus Trough Level Increases Risk of Acute Rejection in Kidney Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569931
|
Nakata S et al. |
Immunosuppressive effect of FK 506 on cytotoxic T lymphocytes and delayed-type hypersensitivity in rats. |
1991 |
Transplant. Proc. |
pmid:1721325
|
Ge J et al. |
Impact of FOXP3 Polymorphisms on the Blood Level of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569929
|
Kapturczak MH et al. |
Pharmacology of calcineurin antagonists. |
2004 |
Transplant. Proc. |
pmid:15041303
|
Yang SS et al. |
A single center, open-label, randomized pilot study to evaluate the safety and efficacy of tacrolimus modified release, Advagraf, versus tacrolimus twice daily, Prograf, in stable renal recipients (single). |
2015 |
Transplant. Proc. |
pmid:25891697
|
Hranjec T et al. |
Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report. |
2008 |
Transplant. Proc. |
pmid:18589195
|
Daly I et al. |
Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176458
|
Jonas S et al. |
Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: ten-year follow-up. |
2002 |
Transplant. Proc. |
pmid:12176459
|
Tsuchida Y et al. |
Vascularized bone marrow allotransplantation in rats prolongs a simultaneous skin allograft. |
1997 |
Transplant. Proc. |
pmid:9142252
|
Zegarska J et al. |
Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496443
|
Fontana I et al. |
Severe rhabdomyolysis and acute renal failure in a kidney transplant patient treated with tacrolimus and chimaeric CD25 monoclonal antibody. |
2004 |
Transplant. Proc. |
pmid:15110640
|
Woodside KJ et al. |
Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile. |
2005 |
Transplant. Proc. |
pmid:15919491
|
Winkler M et al. |
Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring. |
1995 |
Transplant. Proc. |
pmid:7533433
|
Van Thiel DH et al. |
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721357
|
Dahmen U et al. |
Onset of liver regeneration after subtotal resection is inhibited by the use of new immunosuppressive drugs. |
2002 |
Transplant. Proc. |
pmid:12270412
|
Takahara S et al. |
Excellent results following 3 years of tacrolimus immunosuppression in kidney transplantation recipients in Japan: overall analysis of more than 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176500
|
Boggi U et al. |
Neoral versus prograf in simultaneous pancreas-kidney transplantation with portal venous drainage: three-year results of a single-center, open-label, prospective, randomized pilot study. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182772
|
Ribes D et al. |
Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182816
|
Lo CM et al. |
Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong. |
1998 |
Transplant. Proc. |
pmid:9838571
|
Reichenspurner H et al. |
Tacrolimus-based immunosuppressive protocols in lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083062
|
Khanna A et al. |
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123118
|
Alper G and Small SL |
Cerebrospinal fluid after organ transplantation. |
1996 |
Transplant. Proc. |
pmid:8908142
|
Sanghvi A et al. |
Increased cyclosporine uptake by cells pretreated with FK506 and evidence for binding of both drugs to a common intracellular protein. |
1989 |
Transplant. Proc. |
pmid:2468204
|
Winkler M et al. |
Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721389
|
Takagishi K et al. |
Effects of FK-506 on collagen arthritis in mice. |
1989 |
Transplant. Proc. |
pmid:2468205
|
Schmidt RJ et al. |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721390
|
Arita C et al. |
Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report. |
1989 |
Transplant. Proc. |
pmid:2468206
|
Tze WJ et al. |
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. |
1991 |
Transplant. Proc. |
pmid:1721391
|
Cho JH et al. |
Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients. |
2012 |
Transplant. Proc. |
pmid:22310591
|
Ierardi E et al. |
Long-term tacrolimus: a promising therapeutic approach for Crohn's disease. |
2001 |
Transplant. Proc. |
pmid:11377467
|
Jørgensen KA et al. |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176551
|
Castel MA et al. |
Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine. |
2011 Jul-Aug |
Transplant. Proc. |
pmid:21839245
|
Ji SM et al. |
Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy. |
2007 |
Transplant. Proc. |
pmid:17580148
|
Mor E et al. |
Homocysteine levels among transplant recipients: effect of immunosuppressive protocols. |
2001 |
Transplant. Proc. |
pmid:11543802
|
Kokado Y et al. |
Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083515
|
Falconer SJ et al. |
Conversion from twice-daily to once-daily tacrolimus in simultaneous pancreas-kidney transplant patients. |
2014 |
Transplant. Proc. |
pmid:24935313
|
Matsumiya G et al. |
Serum interleukin-6 level after cardiac xenotransplantation in primates. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123586
|
Meloni F et al. |
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. |
2003 |
Transplant. Proc. |
pmid:12826211
|
Boggs S et al. |
FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice. |
1991 |
Transplant. Proc. |
pmid:1721420
|
Ogawa N et al. |
Suppressive effects of combination therapy with mizoribine and FK 506 on the development of accelerated coronary artery disease and myocardial rejection after heart transplantation. |
1996 |
Transplant. Proc. |
pmid:8658710
|
Soran A et al. |
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. |
2000 |
Transplant. Proc. |
pmid:10812157
|
Kamar N et al. |
Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C. |
2004 |
Transplant. Proc. |
pmid:15621141
|
Formica RN et al. |
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12742475
|
Baran DA et al. |
Can initial tacrolimus trough levels be predicted from clinical variables? |
2004 |
Transplant. Proc. |
pmid:15621157
|
Hasegawa A et al. |
Optimal use of tacrolimus in living donor renal transplantation in children. |
2002 |
Transplant. Proc. |
pmid:12176635
|
El-Safa EA et al. |
Paradoxical response to tacrolimus assessed by interleukin-2 gene expression. |
2006 |
Transplant. Proc. |
pmid:17175263
|
Moura Neto A et al. |
Frequency of Thyroid Dysfunction in Patients With Diabetes Mellitus Before and After Liver Transplantation. |
2018 |
Transplant. Proc. |
pmid:29661439
|
van den Berg AP et al. |
Prediction of the inhibition of IL-2 production by calcineurin inhibitors. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267197
|
Kohnle M et al. |
Conversion to tacrolimus in cyclosporin A treated patients with gum hyperplasia. |
1998 |
Transplant. Proc. |
pmid:9723413
|
Alessiani M et al. |
Effect of perioperative donor bone marrow infusion after small bowel transplantation in swine: preliminary results. |
1998 |
Transplant. Proc. |
pmid:9745496
|
Otto C et al. |
Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats. |
1998 |
Transplant. Proc. |
pmid:9723426
|
Chen H et al. |
Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse. |
1998 |
Transplant. Proc. |
pmid:9745497
|
Ott R et al. |
Does conversion of immunosuppressive monotherapy from cyclosporine A to tacrolimus improve bone mineral density in long-term stable liver transplant recipients? |
2003 |
Transplant. Proc. |
pmid:14697971
|
Demir T et al. |
Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy. |
2015 |
Transplant. Proc. |
pmid:26093731
|
Thomson AW et al. |
Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. |
1991 |
Transplant. Proc. |
pmid:1721452
|
Mohsin N et al. |
Low tacrolimus dose requirements in renal transplant recipients in the omani population: implications for pharmacogenetics? |
2005 |
Transplant. Proc. |
pmid:16213259
|
Todo S et al. |
Effect of FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450416
|
Treede H et al. |
Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267444
|
Lee CM et al. |
Monotherapy with tacrolimus for heart and liver transplant: a case report. |
2014 |
Transplant. Proc. |
pmid:24767396
|
Chen H et al. |
FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouse. |
1998 |
Transplant. Proc. |
pmid:9636419
|
Calne RY |
Immunosuppression for organ grafting. |
1991 |
Transplant. Proc. |
pmid:1714646
|
Yoshimura R et al. |
A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450. |
1991 |
Transplant. Proc. |
pmid:1703686
|
Lawen J et al. |
Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750382
|
Hartwig T et al. |
Low-dose sirolimus and tacrolimus in kidney transplantation: first results of a single-center experience. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750383
|